1. Home
  2. Research and Funding
  3. Technology Advancement & Transfer
  4. Research Materials & Licensing
  5. Nicotinic acetylcholine receptor agonists (U.S. Patent Application Number WO 2011116282 A3)

Nicotinic acetylcholine receptor agonists (U.S. Patent Application Number WO 2011116282 A3)

The invention provides novel nicotinic acetylcholine receptor agonists, for example, phaiitasmidine and derivatives thereof, for example a compound of formula (I). Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acet lcholine rece tor a onists.

Resource Details

http://www.google.com/patents/WO2011116282A3

tao@niddk.nih.gov

Garraffo, Hugo

Share